Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Medical nutrition plays an important role in the management of certain chronic conditions such as diabetes, obesity, constipation, malabsorption, maldigestion, etc. It also helps to maintain healthy lifestyle, improve appetite and food intake, lower the risk of nutrient deficiencies, and other health conditions. Medical nutrition is recommended for patients of all ages including infants, adults, and geriatrics who are susceptible to conditions such as diabetes, obesity, renal failures, chronic diseases, neurological diseases, and others. These factors have led to an increase in demand for medical nutrition.
The India Medical Nutrition market is estimated to be valued at US$ 404.1 million in 2021 and is expected to exhibit a CAGR of 8.6% over the forecast period (2021-2028).
Figure 1. India Medical Nutrition Market Value (US$ Mn), and Y-o-Y Growth (%), 2018-2028
Increasing number of product launches by key players are expected to drive the market growth over the forecast period.
The key manufacturers in India are engaged in the development and launch of innovative and novel medical nutrition products, which is expected to drive the growth of India medical nutrition market. For instance, in February 2019, Nutricia International Pvt. Ltd. (Danone India) launched new ProtinexLite, with a nutrition formulation that includes Zero sugar, low GI, high fiber & 27 vital nutrients, specially formulated for adults.
India Medical Nutrition Market Report Coverage
||Market Size in 2021:
||US$ 404.1 Mn
|Historical Data for:
||2017 to 2020
||2021 to 2028
|Forecast Period 2021 to 2028 CAGR:
||2028 Value Projection:
||US$ 718.3 Mn
- North India: Delhi, Rajasthan, Uttar Pradesh, Jammu & Kashmir, Punjab, and Uttaranchal
- South India: Kerala, Karnataka, Tamil Nadu, and Andhra Pradesh
- East India: Bihar, Jharkhand, West Bengal, and Odisha
- West India: Goa, Gujarat, and Maharashtra
- Central India: Madhya Pradesh and Chhattisgarh
- North East India: Arunachal Pradesh, Nagaland, Manipur, Mizoram, Meghalaya, and Assam
- By Nutrition Type: Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, Others
- By Patient Type: Infant Nutrition, Adult Nutrition, Geriatric Nutrition.
- By Indication: Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, Others
- By Route of Administration: Oral, Enteral, Parenteral
- By Distribution Channel: Hospitals, Home Care Settings, Long Term Care, Ambulatory Surgical Centers
Abbott Laboratories, Baxter International Inc., Danone S.A., Nestlé S.A., GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Fresenius Kabi AG, BASF, Zeon Lifesciences Ltd., Mead Johnson & Company, LLC., B. Braun Melsungen AG., Nutrimed Healthcare Pvt. Ltd, and Zenova Bio Nutrition.
- Increasing number of product launches
- The rising prevalence of chronic diseases
|Restraints & Challenges:
- Side effects and high cost of nutritional products
- Lack of awareness regarding nutritional diet among low and middle income economies
Figure 2. India Medical Nutrition Market Share (%), by Nutrition Type, 2021
India Medical Nutrition market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe. The coronavirus (COVID 19) pandemic and lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Private healthcare sector is one of the sectors, which is majorly impacted by the COVID-19 pandemic. Therefore, the Government of India has implemented some initiatives under POSHAN ABHIYAAN, the program provides nutritional support to the underweight and malnutrition patients in India. According to the World Health Organization (WHO) Country Office for India report 2020, India has adopted several initiatives and measures for providing nutritional benefits to the individuals suffering from the malnutrition, and these initiatives provide nutritional diets to needy individuals even in the COVID pandemic period. The government of India also focuses on maximizing maternal, infant, and young child nutrition, protecting the food supply chains, strengthening food security, managing cases of acute malnutrition, accelerating micronutrient supplementation and fortification activities, and strengthening school feeding and nutrition through its initiatives.
India Medical Nutrition market: Restraint
Lack of awareness regarding healthcare, diet, and proper nutrition in low-and middle income economies is a major factor hampering the growth of the India medical nutrition market. For instance, according to the Observer Research Foundation report published in 2017, 73% of the Indians are deficient of protein, while above 90 percent are unaware of the daily requirement of protein. Also, low awareness about nutritional products and diseases associated with the nutritional deficiencies in rural areas of India is expected to result in slow growth of the market. According to the Indian Council of Medical Research (ICMR) in 2017, India’s protein consumption is much lower than 48 gms/day, which could be responsible for causing various disorders such as malnutrition and underweight problems in children and adults.
Major players operating in the India Medical Nutrition market include Abbott Laboratories, Baxter International Inc., Danone S.A., Nestlé S.A., GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Fresenius Kabi AG, BASF, Zeon Lifesciences Ltd., Mead Johnson & Company, LLC., B. Braun Melsungen AG., Nutrimed Healthcare Pvt. Ltd, and Zenova Bio Nutrition.